Literature DB >> 10499045

Hemangiopericytoma of the head and neck.

J F Carew1, B Singh, D H Kraus.   

Abstract

OBJECTIVE/HYPOTHESIS: Hemangiopericytomas are uncommon neoplasms of vascular origin that may arise in the head and neck. Their rare occurrence and variable malignant potential have limited attempts to characterize their clinical behavior. This study reviews the experience in treating hemangiopericytomas of the head and neck at a single institution. STUDY
DESIGN: Retrospective.
METHODS: The records of 12 patients with hemangiopericytomas of the head and neck presenting between 1979 and 1995 were reviewed. Site of origin included the neck (4), oral cavity (3), parotid (2), orbit (1), maxillary sinus (1) and mandible (1). Five patients had lesions characterized as high or intermediate grade histologically, and six had lesions characterized as low grade.
RESULTS: Nine patients were treated with curative intent; three presented either with pulmonary metastasis (2) or unresectable primaries (1) and were treated with radiation therapy and/or palliative Adriamycin-based chemotherapy. Patients treated with curative intent underwent a variety of surgical resections dictated by tumor location and size. Four patients received postoperative radiation therapy to a median dose of 60 Gy, for positive surgical margins (2), high-grade histology (1) or a recurrent lesion (1). Five-year overall survival in patients treated surgically was 87.5%. A single mortality occurred in a patient with a recurrent high-grade lesion who failed at local, regional, and distant sites. Median follow-up of survivors was 73 months.
CONCLUSION: The clinical behavior of hemangiopericytomas appears to be related to their histological grade. Aggressive local therapy including surgery and radiation therapy appears to be effective in providing tumor control.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10499045     DOI: 10.1097/00005537-199909000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

Review 1.  [Perivascular neoplasms of skin and soft tissues. A review].

Authors:  T Mentzel
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

2.  Concurrent Cochlear Implantation with Resection of Skull Base Hemangiopericytoma following Sudden Deafness in an Only Hearing Ear.

Authors:  Evan R Ransom; Kevin D Judy; Douglas C Bigelow
Journal:  Skull Base       Date:  2010-07

3.  [Hemangiopericytoma (extrapleural solitary fibrous tumour). Exemplified and discussed on the basis of two cases].

Authors:  F Wilde; M Neid; T Schulz; I Sterker; A Hemprich; B Frerich
Journal:  Mund Kiefer Gesichtschir       Date:  2005-11

4.  Sinonasal Glomangiopericytoma with Prolonged Postsurgical Follow-Up.

Authors:  Alex J Gordon; Michael R Papazian; Michael Chow; Aneek Patel; Dimitris G Placantonakis; Seth Lieberman; Babak Givi
Journal:  J Neurol Surg Rep       Date:  2022-07-10

Review 5.  Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base.

Authors:  Fabian Sommer
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057

Review 6.  Primary haemangiopericytoma of the parapharyngeal space: an unusual tumour and review of the literature.

Authors:  E N Fountoulakis; E Papadaki; I Panagiotaki; E Giannikaki; G Lagoudianakis; J Bizakis
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-03-16       Impact factor: 2.124

Review 7.  Hemangiopericytoma/solitary fibrous tumor of the cranial base: a case series and literature review.

Authors:  Zhouying Peng; Yumin Wang; Yaxuan Wang; Qinxuan Li; Yan Fang; Ruohao Fan; Hua Zhang; Weihong Jiang
Journal:  BMC Surg       Date:  2022-07-27       Impact factor: 2.030

Review 8.  A case of hemangiopericytoma of the soft palate with articulate disorder and dysphagia.

Authors:  Yasuyuki Michi; Miho Suzuki; Kazuto Kurohara; Kiyoshi Harada
Journal:  Int J Oral Sci       Date:  2013-05-24       Impact factor: 6.344

9.  Sacro-anterior haemangiopericytoma: a case report.

Authors:  Xiu-Hong Ge; Shuai-Shuai Liu; Hu-Sheng Shan; Zhi-Min Wang; Qian-Wen Li
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.